Ability Biologics
Marc-Olivier Sirard, CPA-CA, currently serves as an Investment Manager at Fonds de solidarité FTQ since December 2016, and also holds positions as a Board Member for Ability Biologics and a member of the New Generation Committee at Réseau Capital. Since January 2013, Marc-Olivier has been a teacher at Cégep Marie-Victorin, specializing in financial management. Previously, Marc-Olivier contributed as a Board Member for LQT Therapeutics, Inc. and worked as a Senior Financial Analyst at Lightspeed POS. Other relevant experience includes serving as a Junior Director in restructuring at Raymond Chabot Grant Thornton and as a Senior Auditor at BDO Canada. Marc-Olivier holds a Graduate Diploma in Public Accounting and a Bachelor of Commerce in Accounting from McGill University, as well as a Chartered Professional Accountant designation from CPA Canada.
This person is not in any teams
Ability Biologics
1 followers
Our Mission: Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics. We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.